To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC8627 | Saquinavir Featured |
Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
More description
|
|
| DC10435 | RSV604 racemate |
RSV604 racemate is a racemic mixture, shows less potency against strains of respiratory syncytial virus (RSV) than the S-isomer.
More description
|
|
| DCAPI1325 | Rifabutin (Mycobutin) |
Rifabutin (Mycobutin)
More description
|
|
| DC4148 | Retapamulin |
Retapamulin is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM.
More description
|
|
| DC9479 | Raltegravir (potassium salt) |
Raltegravir potassium salt(MK0518 potassium salt) is a potent integrase (IN) inhibitor, used to treat HIV infection.
More description
|
|
| DC8930 | Rafoxanide |
Rafoxanide is a salicylanilide used as an antiparasitic agent.
More description
|
|
| DCAPI1553 | Pyrimethamine |
Pyrimethamine is a potent inhibitor of multi-drug and toxin extrusion transporters. This compound inhibits Mdr-1(Pgp) and thus allows for active drugs to stay within the cell for longer periods of time, increasing their effectiveness by preventing efflux
More description
|
|
| DC11808 | PF-46396 |
PF-46396 is a specific small-molecule inhibitor of HIV-1 Gag maturation that interferes specifically with the cleavage of the CA/SP1 (p25) Gag precursor to the mature CA (p24) protein.
More description
|
|
| DCAPI1121 | Peramivir |
Peramivir
More description
|
|
| DC11259 | NTCP binder peptide WL4 |
NTCP binder peptide WL4 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV, sodium taurocholate cotransporting polypeptide (NTCP, Kd=42 nM), reduces HBs antigen levels in culture supernatants with IC50 of 0.66 uM.
More description
|
|
| DC11260 | NTCP binder peptide WD1 |
NTCP binder peptide WD1 is a macrocyclic peptide, pan-genotypic inhibitor of HBV cellular entry via targeting the cell-surface receptor for HBV, sodium taurocholate cotransporting polypeptide (NTCP, Kd=15 nM), reduces HBs antigen levels in culture supernatants.
More description
|
|
| DC11016 | NOSO-502 |
NOSO-502 (NOSO502) is a novel inhibitor of bacterial translation, has MIC values of 0.5-4 ug/ml against standard Enterobacteriaceae strains and carbapenem-resistant Enterobacteriaceae (CRE) isolates that produce KPC, AmpC, or OXA enzymes and metallo-β-lactamases.
More description
|
|
| DC8178 | Beclabuvir(BMS-791325) |
non-nucleoside inhibitor of the NS5B
More description
|
|
| DC7791 | NITD 609 |
NITD 609 is a novel and potent drug
candidate for the treatment of
uncomplicated malaria
More description
|
|
| DC9477 | NBD-557 |
NBD-557 is a potentially HIV-1 inhibitor.
More description
|
|
| DCAPI1293 | Nanchangmycin |
Nanchangmycin (dianemycin) is a polyether antibiotic with similar structure to dianemycin and is very active against a broad spectrum of harmful nematodes and insects but not for for mammals and plants.
More description
|
|
| DC10258 | Mebendazole |
Mebendazole is a synthetic benzimidazole derivate and anthelmintic agent. Mebendazole interferes with the reproduction and survival of helminths by inhibiting the formation of their cytoplasmic microtubules, thereby selectively and irreversibly blocking g
More description
|
|
| DC8775 | LED209 |
LED209 is a potent QseC inhibitor that blocks both norepinephrine- and epinephrine-triggered QseC-dependent virulence gene expression at 5 pM in vitro.
More description
|
|
| DC10934 | JBJ-16-111 |
JBJ-16-111 is a small molecule that inhibits dengue virus (DENV) by binding to its envelope protein E..
More description
|
|
| DCAPI1366 | Itraconazole (Sporanox) |
Itraconazole (Sporanox)
More description
|
|
| DC11494 | INX-08189 |
INX-08189 is a phosphoramidate prodrug of O-6-methyl-2-C-methyl guanosine, potent inhibitor of HCV NS5B polymerase with IC50 of 10 nM in replicon assay.
More description
|
|
| DC9472 | HIV-1 integrase inhibitor 2 |
HIV-1 integrase inhibitor, in the treatment of human immunodeficiency virus (HIV) infection.
More description
|
|
| DC9473 | HIV-1 integrase inhibitor |
HIV-1 integrase inhibitor ((Z)-4-(3-(azidomethyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid) is uesful for anti-HIV.
More description
|
|
| DC11297 | GS-9822 |
GS-9822 is a novel, potent NCINI with a higher barrier to resistance relative to early prototype NCINIs, including GS-9695.
More description
|
|
| DC8893 | Garenoxacin Mesylate hydrate |
Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.
More description
|
|
| DC8929 | Garenoxacin |
Garenoxacin is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.
More description
|
|
| DC7824 | Fosfluconazole(INN) |
Fosfluconazole (INN) is a water-soluble phosphate prodrug of fluconazole
More description
|
|
| DC8047 | VRT-1353385 |
For the detailed information of VRT-1353385, the solubility of VRT-1353385 in water, the solubility of VRT-1353385 in DMSO, the solubility of VRT-1353385 in PBS buffer, the animal experiment (test) of VRT-1353385, the cell expriment (test) of VRT-1353385, the in vivo, in vitro and clinical trial test of VRT-1353385, the EC50, IC50,and affinity,of VRT-1353385, For the detailed information of VRT-1353385, the solubility of VRT-1353385 in water, the solubility of VRT-1353385 in DMSO, the solubility of VRT-1353385 in PBS buffer, the animal experiment (test) of VRT-1353385, the cell expriment (test) of VRT-1353385, the in vivo, in vitro and clinical trial test of VRT-1353385, the EC50, IC50,and affinity,of VRT-1353385, Please contact DC Chemicals..
More description
|
|
| DC9350 | Faropenem daloxate |
Faropenem daloxate is the first oral penem in a new class of beta-lactam antibiotics.
More description
|
|
| DCAPI1011 | Famciclovir (Famvir) |
Famciclovir (Famvir)
More description
|
|